New targets for disease modifying osteoarthritis drugs: Chondrogenesis and Runx1

Annals of the Rheumatic Diseases

Volumn 72, Issue 5, 2013, Pages 631-634

  Blanco, Francisco J ^a,b,c   Ruiz Romero, Cristina ^a,c  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; CORE BINDING FACTOR BETA; DISEASE MODIFYING ANTIRHEUMATIC DRUG; KARTOGENIN; MINOCYCLINE; NERVE CELL ADHESION MOLECULE; PARATHYROID HORMONE[1-34]; PROTEIN INHIBITOR; SONIC HEDGEHOG PROTEIN; TD 198946; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

CARTILAGE CELL; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; CHONDROGENESIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TREATMENT RESPONSE;

EID: 85027919945     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202652     Document Type: Review

References (31)

1. Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012;64:1697-707.
2. Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet 2005;365:965-73. (Pubitemid 41071431)
3. Hunter DJ. Pharmacologic therapy for osteoarthritis, the era of disease modification. Nat Rev Rheumatol 2011;7:13-22.
4. Felson DT, Kim Y. The futility of current approaches to chondroprotection. Arthritis Rheum 2007;56:1378-83. (Pubitemid 46764064)
5. Zuscik MJ, Hilton MJ, Zhang X, et al. Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest 2008;118:429-38. (Pubitemid 351206530)
6. Goldring MB. Chondrogenesis, chondrocyte differentiation and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskel Dis 2012;4:269-85.
7. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011;377:2115-26.
8. Yano F, Hojo H, Ohba S, et al. A novel disease-modifying osteoarthritis drug candidate targeting Runx1. Ann Rheum Dis 2013;72:748-53.
9. Sandell LJ, Morris N, Robbins JR, et al. Alternatively spliced type II procollagen mRNAs define distinct population of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol 1991;114:1307-19. (Pubitemid 21909888)
10. Yoshida CA, Yamamoto H, Fujita T, et al. Runx-2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 2004;18:952-63. (Pubitemid 38529663)
11. Mattot V, Raes MB, Henriet P, et al. Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. J Cell Sci 1995;108:529-35.
12. Sato S, Kimura A, Ozdemir J, et al. The distinct role of the runx proteins in chondrocyte differentiation and intervertebral disc degeneration findings in Murine models and in human disease. Arthritis Rheum 2008;58:2764-75.
13. Wang JY, Belflower RM, Dong YF, et al. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. J Bone Miner Res 2005;20:1624-36. (Pubitemid 41243551)
14. Johnson K, Zhu S, Tremblay MS, et al. A stem cell-based approach to cartilage repair. Science 2012;11:717-21.
15. Rocha B, Calamia V, Mateos J, et al. Metabolic labeling of human bone marrow mesenchymal stem cells for the quantitative analysis of their chondrogenic differentiation. J Proteome Res 2012;11:5350-61.
16. Rolauffs B, Williams JM, Aurich M, et al. Proliferative remodeling of the spatial organization of human superficial chondrocytes distant from focal early osteoarthritis. Arthritis Rheum 2010;62:489-98.
17. Alsalameh S, Amin R, Gemba T, et al. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 2004;50:1522-32. (Pubitemid 38608074)
18. Dowthwaite GP, Bishop JC, Redman SN, et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci 2004; 117:889-97. (Pubitemid 38386946)
19. Gerter R, Kruegel J, Miosge N. New insights into cartilage repair, the role of migratory progenitor cells in osteoarthritis. Matrix Biol 2012;31: 208-13.
20. Taniguchi N, Carames B, Ronfani L, et al. Agingrelated loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis. Proc Natl Acad Sci USA 2009;106:1181-6.
21. Grogan SP, Miyaki S, Asahara H, et al. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res Ther 2009; 11:R85.
22. Tchetina EV, Squires G, Poole AR. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 2005;32:876-86. (Pubitemid 40676499)
23. Koelling S, Kruegel J, Irmer M, et al. Migragory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell 2009;4:324-35.
24. Karlsson C, Dehne T, Lindahl A, et al. Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage 2010;18:581-92.
25. Hunziker EB, Rosenberg LC. Repair of partial-thickness defects in articular cartilage:cell recruitment form the synovial membrane. J Bone Joint Surg Am 1996;78:721-33. (Pubitemid 26154259)
26. Hermida-Gomez T, Fuentes-Boquete I, Gimeno-Longas MJ, et al. Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes. J. Rheumatol 2011;38:339-49.
27. Jones EA, English A, Henshaw K, et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 2004;50:817-27. (Pubitemid 38326182)
28. De Bari C, DellAcio F, Tylzanowski P, et al. Multipotent mesenchymal cstem cells from adult human synovial membrane. Arthritis Rheum 2001;44:1928-42. (Pubitemid 32758241)
29. Echtermeyer F, Bertrand J, Dreier R, et al. Syndican-44 regulates ADMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 2009;15:1072-76.
30. Lin AC, Seeto Bl, Bartoszko JM, et al. Modulating hedgehog signalling can attenuate the severity of osteoarthritis. Nat Med 2009;15:1421-25.
31. Sampson ER, Hilton MJ, Tian Y, et al. Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. Sci Transl Med 2011;3:101ra93.